Japan's biggest drug maker, Takeda Pharmaceutical, is moving its R&D headquarters from Japan to Illinois in the next few months. And in a bid to further shake up its development efforts, the pharma company has outlined a host of executive appointments for its realigned global development operations. "Takeda is making meaningful changes in structure and governance through this reorganization...which we believe will further strengthen our global operations structure," said President Yasuchika Hasegawa in a statement. Takeda report